Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis

• المؤلفون الرئيسيون: Irma Convertino (مؤلف), Valentina Lorenzoni (مؤلف), Rosa Gini (مؤلف), Giuseppe Turchetti (مؤلف), Elisabetta Fini (مؤلف), Sabrina Giometto (مؤلف), Claudia Bartolini (مؤلف), Olga Paoletti (مؤلف), Sara Ferraro (مؤلف), Emiliano Cappello (مؤلف), Giulia Valdiserra (مؤلف), Marco Bonaso (مؤلف), Corrado Blandizzi (مؤلف), Marco Tuccori (مؤلف), Ersilia Lucenteforte (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2023-03-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare utilization patterns, and direct costs from a healthcare system perspective. This retrospective cohort study was performed using Tuscan administrativ...